Literature DB >> 21304439

Evidence that FoxP3+ regulatory T cells may play a role in promoting long-term acceptance of composite tissue allotransplants.

Larry D Bozulic1, Yujie Wen, Hong Xu, Suzanne T Ildstad.   

Abstract

BACKGROUND: FoxP3/CD4/CD25 regulatory T cells (Treg) play an important role in maintaining peripheral tolerance and are potent suppressors of T-cell activation. In this study, we evaluated the role of Treg in peripheral tolerance to composite tissue allografts (CTA).
METHODS: Mixed allogeneic chimeric rats were prepared by preconditioning recipients with anti-αβ-T-cell receptor monoclonal antibody followed by total body irradiation. Animals received T-cell-depleted August Copenhagen Irish bone marrow cells followed by antilymphocyte serum and FK-506. A modified osteomyocutaneous hindlimb flap composed of bone and all limb tissue components was placed in animals with chimerism greater than or equal to 1% on day 28. Recipients with CTA surviving more than or equal to 6 months were evaluated for Treg. Skin samples from tolerant long-term allogeneic transplanted, syngeneic transplanted, rejected, and naïve animals were immunostained with fluorochrome-conjugated anti-FoxP3 and anti-CD4 monoclonal antibody and visualized under a laser confocal microscope.
RESULTS: Significant CD4/FoxP3 Treg infiltrates were observed in tolerant donor-allograft skin samples. No graft infiltrating FoxP3 cells were observed in rejector, naïve, or skin from syngeneic CTA. In parallel experiments, mixed leukocyte reaction assays were performed to investigate the suppressor function of Treg cells. Splenocytes from tolerant, rejected, and naïve rats were sorted by flow cytometry for CD4/CD25 T cells. Treg demonstrated similar suppressive levels between the three groups.
CONCLUSIONS: These data suggest that Treg may play an important role in maintenance of tolerance and promoting graft acceptance in long-term CTA acceptors and may explain the favorable outcomes observed in clinical CTA recipients.
© 2011 by Lippincott Williams & Wilkins

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21304439      PMCID: PMC3592205          DOI: 10.1097/TP.0b013e31820fafb4

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  36 in total

Review 1.  The complementary roles of deletion and regulation in transplantation tolerance.

Authors:  Robert I Lechler; Oliver A Garden; Laurence A Turka
Journal:  Nat Rev Immunol       Date:  2003-02       Impact factor: 53.106

Review 2.  Tolerance in mixed chimerism - a role for regulatory cells?

Authors:  Josef Kurtz; Thomas Wekerle; Megan Sykes
Journal:  Trends Immunol       Date:  2004-10       Impact factor: 16.687

3.  Matching at the MHC class I K locus is essential for long-term engraftment of purified hematopoietic stem cells: a role for host NK cells in regulating HSC engraftment.

Authors:  Yiming Huang; Francine Rezzoug; Paula M Chilton; H Leighton Grimes; Daniel E Cramer; Suzanne T Ildstad
Journal:  Blood       Date:  2004-03-30       Impact factor: 22.113

4.  Reconstitution with syngeneic plus allogeneic or xenogeneic bone marrow leads to specific acceptance of allografts or xenografts.

Authors:  S T Ildstad; D H Sachs
Journal:  Nature       Date:  1984 Jan 12-18       Impact factor: 49.962

5.  Mixed xenogeneic chimerism induces donor-specific humoral and cellular immune tolerance for cardiac xenografts.

Authors:  Yolonda L Colson; Hong Xu; Yiming Huang; Suzanne T Ildstad
Journal:  J Immunol       Date:  2004-11-01       Impact factor: 5.422

6.  Phenotypic characterization of a novel bone marrow-derived cell that facilitates engraftment of allogeneic bone marrow stem cells.

Authors:  C L Kaufman; Y L Colson; S M Wren; S Watkins; R L Simmons; S T Ildstad
Journal:  Blood       Date:  1994-10-15       Impact factor: 22.113

7.  Mixed allogeneic chimerism in the rat. Donor-specific transplantation tolerance without chronic rejection for primarily vascularized cardiac allografts.

Authors:  Y L Colson; K Zadach; M Nalesnik; S T Ildstad
Journal:  Transplantation       Date:  1995-11-15       Impact factor: 4.939

8.  Characterization of mixed allogeneic chimeras. Immunocompetence, in vitro reactivity, and genetic specificity of tolerance.

Authors:  S T Ildstad; S M Wren; J A Bluestone; S A Barbieri; D H Sachs
Journal:  J Exp Med       Date:  1985-07-01       Impact factor: 14.307

9.  Infectious tolerance: human CD25(+) regulatory T cells convey suppressor activity to conventional CD4(+) T helper cells.

Authors:  Helmut Jonuleit; Edgar Schmitt; Hacer Kakirman; Michael Stassen; Jürgen Knop; Alexander H Enk
Journal:  J Exp Med       Date:  2002-07-15       Impact factor: 14.307

10.  Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3.

Authors:  WanJun Chen; Wenwen Jin; Neil Hardegen; Ke-Jian Lei; Li Li; Nancy Marinos; George McGrady; Sharon M Wahl
Journal:  J Exp Med       Date:  2003-12-15       Impact factor: 14.307

View more
  10 in total

1.  Combined treatment with regulatory T cells and vascularized bone marrow transplantation creates mixed chimerism and induces donor-specific tolerance to vascularized composite allografts without cytoreductive conditioning.

Authors:  Jeng-Yee Lin; Feng-Chou Tsai; Christopher Glenn Wallace; Wei-Chao Huang; Fu-Chan Wei; Shuen-Kuei Liao
Journal:  Chimerism       Date:  2013 Jan-Mar

2.  Tolerance to vascularized composite allografts in canine mixed hematopoietic chimeras.

Authors:  David W Mathes; Billanna Hwang; Scott S Graves; James Edwards; Jeff Chang; Barry E Storer; Tiffany Butts-Miwongtum; George E Sale; Richard A Nash; Rainer Storb
Journal:  Transplantation       Date:  2011-12-27       Impact factor: 4.939

3.  Efficacy of single-agent immunosuppressive regimens in a murine model of vascularized composite allotransplantation.

Authors:  Yinan Guo; Franka Messner; Byoung Chol Oh; Gerald Brandacher; Joanna W Etra; Sarah E Beck; Richa Kalsi; Georg J Furtmüller; Stefan Schneeberger
Journal:  Transpl Int       Date:  2020-05-12       Impact factor: 3.782

4.  Simultaneous bone marrow and composite tissue transplantation in rats treated with nonmyeloablative conditioning promotes tolerance.

Authors:  Hong Xu; Deborah M Ramsey; Shengli Wu; Larry D Bozulic; Suzanne T Ildstad
Journal:  Transplantation       Date:  2013-01-27       Impact factor: 4.939

5.  Thioredoxin priming prolongs lung allograft survival by promoting immune tolerance.

Authors:  Hanbo Hu; Xiaoyan Zhu; Sunil Joshi; Li Lu; Chang-Qing Xia; Jawaharlal M Patel
Journal:  PLoS One       Date:  2015-05-01       Impact factor: 3.240

Review 6.  Improving the safety of tolerance induction: chimerism and cellular co-treatment strategies applied to vascularized composite allografts.

Authors:  Wei-Chao Huang; Jeng-Yee Lin; Christopher Glenn Wallace; Fu-Chan Wei; Shuen-Kuei Liao
Journal:  Clin Dev Immunol       Date:  2012-10-22

7.  Role of donor-specific regulatory T cells in long-term acceptance of rat hind limb allograft.

Authors:  Yaojun Wang; Zhao Zheng; Yunchuan Wang; Jiaqi Liu; Na Li; Xiaolong Hu; Fu Han; Yang Liu; Dahai Hu
Journal:  PLoS One       Date:  2012-08-29       Impact factor: 3.240

Review 8.  The need for inducing tolerance in vascularized composite allotransplantation.

Authors:  Kadiyala V Ravindra; Hong Xu; Larry D Bozulic; David D Song; Suzanne T Ildstad
Journal:  Clin Dev Immunol       Date:  2012-10-31

9.  In situ recruitment of regulatory T cells promotes donor-specific tolerance in vascularized composite allotransplantation.

Authors:  James D Fisher; Wensheng Zhang; Stephen C Balmert; Ali M Aral; Abhinav P Acharya; Yalcin Kulahci; Jingjing Li; Heth R Turnquist; Angus W Thomson; Mario G Solari; Vijay S Gorantla; Steven R Little
Journal:  Sci Adv       Date:  2020-03-13       Impact factor: 14.136

10.  Evaluation of Thymic Output and Regulatory T Cells in Kidney Transplant Recipients with Chronic Antibody-Mediated Rejection.

Authors:  Abbas Shahi; Saeedeh Salehi; Shima Afzali; Ladan Gol Mohammad Pour Afrakoti; Marzie Esmaeili; Farzaneh Bagherpour; Ziba Aghsaeifard; Sanaz Dehghani; Gholamreza Pourmand; Ali Akbar Amirzargar
Journal:  Biomed Res Int       Date:  2021-02-09       Impact factor: 3.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.